Search

everythinglearnresearchcommunity

for

Search:↓

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Different skin diseases show unique patterns of skin cell separation, cell death, and granular layer changes.

Using quantitative traits in genetics can improve understanding and management of skin health and conditions.

New genetic discoveries in alopecia areata could lead to better treatments.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Some alternative medicine treatments might work for skin conditions, but their effectiveness and safety differ a lot.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

New ginseng compounds may help treat degenerative diseases.

Exosomes could help treat skin and hair issues by improving healing and reducing stress.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

The document concludes that the discussed biological mechanisms and potential therapies are not related to hair loss or hair growth.

Skin organoids help improve wound healing and tissue repair.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.